New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Notice bibliographique
Résumé
Abstract Introduction: Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogeneous disease that is characterized by recurrent translocations and somatic mutations. The prognosis of DLBCL has been associated with clinical features, cell-of-origin (COO) and genetic aberrations. The aim of this study was to determine whether somatic mutations are associated with overall survival (OS) in patients with DLBCL who have been treated with R-CHOP, and whether these mutations can be incorporated into a model to better predict survival. Methods: We identified 340 patients between 2000-2016 from two institutions with a diagnosis of de novo DLBCL treated with R-CHOP. A custom targeted panel with 334 genes which included frequently mutated genes in B-cell lymphoma was used and the captured DNA was sequenced on an Illumina HiSeq 2500. Cases were evaluated by immunohistochemistry (IHC: Hans algorithm; MYC and BCL2 expression), nCounter Nanostring (Lymph2Cx), and FISH analysis for BCL2, BCL6, and MYC rearrangement. OS was estimated using the Kaplan-Meier method. Multivariant modeling of OS was performed incorporating clinical features, IHC, COO by Nanostring, FISH, and mutation status of the most frequently mutated genes (≥5%). LASSO regression was performed to select for significant variables and determine coefficients for these variables and risk scores were calculated based on various fitted models. Concordance C-index was used to assess the discriminatory ability of different models, and three risk groups were determined by stratifying the risk scores in the final model. Results: 199 patients (median age 60 years, M:F ratio 1.4:1) had complete clinical and sequencing data. The germinal center B-cell phenotype (GCB) was more common (69%) than the activated B-cell phenotype (ABC; 26%), and 5% were unclassified by COO. The most frequently mutated genes were KMT2D (31%), CREBBP (21%), and TP53 (20%). Double/triple-hit (DH) lymphomas comprised of 11% of the cases, and 13% were double-protein expressors (MYC and BCL2) only. Significant variables selected by LASSO included factors in the IPI, FISH analysis, and 3 mutated genes (KMT2D, PIM1, and MEF2B). A formula was developed using the individual factors (elevated LDH, age ≥60 years, presence of extranodal sites, stage ≥ 3, male, DH status, and mutations in KMT2D, PIM1, and/or MEF2B. A three risk group model (m3D-IPI) was constructed based on these significant variables and its coefficients were superior in discriminating OS compared to the IPI alone (C-index: 0.830 vs. 0.775; Figures A and B). Within IPI group 3 (Figure C), Lasso 3 (high risk) identified patients that had a poor prognosis (p=0.022). In IPI group 4 (Figure D), Lasso 2 (intermediate risk) identified patients that had a better prognosis (p=0.0074). A simplified risk model using the same variables was also developed by assigning one point for each variable present, and these findings were validated in an independent cohort of DLBCL (Reddy et al, Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell 2017;171(2):481-94). Conclusion: In this study, we incorporated mutation analysis of select genes with clinical risk factors and developed an improved risk model for patients with DLBCL treated with first-line therapy. Disclosures Herrera: Pharmacyclics: Consultancy, Research Funding; Gilead Sciences: Research Funding; Merck, Inc.: Consultancy, Research Funding; AstraZeneca: Research Funding; KiTE Pharma: Consultancy, Research Funding; Seattle Genetics: Research Funding; Bristol-Myers Squibb: Consultancy, Research Funding; Genentech: Consultancy, Research Funding; Immune Design: Research Funding.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,002 | 0,003 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,001 |
| Bibliométrie | 0,001 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,001 | 0,000 |
| Science ouverte | 0,001 | 0,001 |
| Intégrité de la recherche | 0,001 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,002 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».